AcelRx Pharma (ACRX)

2.78 -0.09 (3.14%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/8/18 *Est.)

Latest Headlines

AcelRx Pharma (ACRX) CEO Buys 10K Shares December 13, 2018 6:47 AM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: Dec 12 Filed by: Angotti Vincent J. December 12, 2018 7:32 PM - SEC Filing AcelRx Pharmaceuticals to Host Analyst and Investor Day on December 11 November 29, 2018 4:35 PM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Nov 19 Filed by: Palmer Pamela P November 19, 2018 6:14 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Nov 15 Filed by: EDWARDS MARK G November 15, 2018 6:36 PM - SEC Filing AcelRx Pharmaceuticals to Present at the 17th Annual ASRA Pain Medicine Meeting November 14, 2018 4:05 PM - PR NewsWire Form 8-K ACELRX PHARMACEUTICALS For: Nov 09 November 13, 2018 5:20 PM - SEC Filing Form 424B5 ACELRX PHARMACEUTICALS November 13, 2018 5:18 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Nov 13 Filed by: ASADORIAN RAFFI November 13, 2018 1:54 PM - SEC Filing Pre-Open Movers 11/09: (FNSR) (HTZ) (REV) Higher; (YELP) (NBEV) (UEPS) Lower (more...) November 9, 2018 9:26 AM - StreetInsider AcelRx Pharma (ACRX) Prices 12.698M Share Common Offering at $3.15/Sh November 9, 2018 9:12 AM - StreetInsider AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock November 9, 2018 9:10 AM - PR NewsWire AcelRx Pharma (ACRX) Announces Proposed Common Offering November 9, 2018 7:07 AM - StreetInsider Form 424B5 ACELRX PHARMACEUTICALS November 9, 2018 7:06 AM - SEC Filing AcelRx Pharmaceuticals Announces Proposed Public Offering of Common Stock November 9, 2018 7:00 AM - PR NewsWire AcelRx Pharmaceuticals to Present at Credit Suisse 27th Annual Healthcare Conference November 7, 2018 5:19 PM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Nov 02 Filed by: Hamel Lawrence G November 5, 2018 5:32 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Nov 02 Filed by: Dasu Badri N November 5, 2018 5:26 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Nov 02 Filed by: ASADORIAN RAFFI November 5, 2018 5:25 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Nov 02 Filed by: Palmer Pamela P November 5, 2018 5:23 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Nov 02 Filed by: Angotti Vincent J. November 5, 2018 4:52 PM - SEC Filing AcelRx Pharmaceuticals (ACRX) PT Raised to $9 at Cantor Fitzgerald November 5, 2018 11:39 AM - StreetInsider Form 10-Q ACELRX PHARMACEUTICALS For: Sep 30 November 5, 2018 9:25 AM - SEC Filing Form 8-K ACELRX PHARMACEUTICALS For: Nov 02 November 2, 2018 4:16 PM - SEC Filing AcelRx Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update November 2, 2018 4:05 PM - PR NewsWire Form 8-K ACELRX PHARMACEUTICALS For: Nov 02 November 2, 2018 3:06 PM - SEC Filing AcelRx Pharma (ACRX) to Resume Trading at 2:15 pm ET November 2, 2018 2:01 PM - StreetInsider AcelRx (ACRX) Confirms FDA approval of DSUVIA November 2, 2018 1:58 PM - StreetInsider AcelRx announces FDA approval of DSUVIA™ November 2, 2018 1:56 PM - PR NewsWire AcelRx Pharma (ACRX) dsuvia said approved by the FDA November 2, 2018 1:22 PM - StreetInsider AcelRx Pharma (ACRX) halted, news pending November 2, 2018 12:58 PM - StreetInsider Pre-Open Stock Movers 10/23: (CDNS) (SENS) (AUDC) Higher; (TLRY) (CAT) (MMM) Lower (more...) October 23, 2018 9:31 AM - StreetInsider B.Riley/FBR Starts AcelRx Pharmaceuticals (ACRX) at Buy October 23, 2018 6:24 AM - StreetInsider AcelRx Pharma (ACRX) Comments Following Positive FDA Advisory Committee Meeting October 19, 2018 3:16 PM - StreetInsider AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting October 19, 2018 3:15 PM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Oct 15 Filed by: Hamel Lawrence G October 16, 2018 4:32 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Oct 15 Filed by: Dasu Badri N October 16, 2018 4:30 PM - SEC Filing DSUVIA Efficacy and Safety Data to be Presented at the American Society of Anesthesiologists (ASA) Annual Conference October 15, 2018 4:01 PM - PR NewsWire AcelRx Pharmaceuticals (ACRX) PT Raised to $8 at H.C. Wainwright October 15, 2018 12:27 PM - StreetInsider Pre-Open Movers 10/15: (ACRX) (ABCD) (LLL) Higher; (SHLD) (NTRI) Lower (more...) October 15, 2018 9:22 AM - StreetInsider Jefferies Upgrades AcelRx Pharmaceuticals (ACRX) to Buy October 15, 2018 6:09 AM - StreetInsider AcelRx Pharma (ACRX) Confirms FDA Advisory Committee Recommends Approval of DSUVIA for Treatment of Moderate-To-Severe Acute Pain October 12, 2018 4:16 PM - StreetInsider FDA Advisory Committee Recommends Approval Of DSUVIA For The Treatment Of Moderate-To-Severe Acute Pain October 12, 2018 4:15 PM - PR NewsWire AcelRx Pharma's (ACRX) Pain-Killer Dsuvia Wins FDA Panel Backing, Vote 10-3 to Support Approval - Bloomberg October 12, 2018 2:53 PM - StreetInsider AcelRx Pharma (ACRX) Stock Trading Halted Ahead of FDA Advisory Committee to Review DSUVIA NDA October 12, 2018 7:11 AM - StreetInsider AcelRx Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review DSUVIA New Drug Application October 12, 2018 7:10 AM - PR NewsWire AcelRx Pharma (ACRX) Halted, News Pending October 12, 2018 6:55 AM - StreetInsider AcelRx (ACRX) Briefing Docs Bode Well for Vote - H.C. Wainwright October 10, 2018 12:30 PM - StreetInsider AcelRx (ACRX) Briefing Docs 'Positive', Expect Favorable Vote - Oppenheimer October 10, 2018 12:24 PM - StreetInsider AcelRx Pharmaceuticals (ACRX) PT Raised to $10 at Ladenburg Thalmann October 10, 2018 9:56 AM - StreetInsider AcelRx (ACRX) Could Have Positive AdCom Vote - Cantor Fitzgerald October 10, 2018 9:45 AM - StreetInsider AcelRx Pharma (ACRX) shares on watch as FDA briefing docs released October 10, 2018 8:05 AM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: Sep 24 Filed by: Hamel Lawrence G September 26, 2018 5:55 PM - SEC Filing AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October September 25, 2018 4:05 PM - PR NewsWire Full Article List